Konicki PE - Search Results

1

Beneficial effects of nalmefene augmentation in neuroleptic-stabilized schizophrenic patients.

Rapaport MH, Wolkowitz O, Kelsoe JR, Pato C, Konicki PE, Pickar D. Rapaport MH, et al. Among authors: konicki pe. Neuropsychopharmacology. 1993 Sep;9(2):111-5. doi: 10.1038/npp.1993.49. Neuropsychopharmacology. 1993. PMID: 8105790 Clinical Trial.

2

Cerebrospinal fluid and plasma monoamine metabolites and their relation to psychosis. Implications for regional brain dysfunction in schizophrenia.

Pickar D, Breier A, Hsiao JK, Doran AR, Wolkowitz OM, Pato CN, Konicki PE, Potter WZ. Pickar D, et al. Among authors: konicki pe. Arch Gen Psychiatry. 1990 Jul;47(7):641-8. doi: 10.1001/archpsyc.1990.01810190041006. Arch Gen Psychiatry. 1990. PMID: 1694425

3

Monoamine neurotransmitter interactions in drug-free and neuroleptic-treated schizophrenics.

Hsiao JK, Colison J, Bartko JJ, Doran AR, Konicki PE, Potter WZ, Pickar D. Hsiao JK, et al. Among authors: konicki pe. Arch Gen Psychiatry. 1993 Aug;50(8):606-14. doi: 10.1001/archpsyc.1993.01820200016002. Arch Gen Psychiatry. 1993. PMID: 7688209

4

Neurochemical and neural mechanisms of positive and negative symptoms in schizophrenia.

Pickar D, Litman RE, Konicki PE, Wolkowitz OM, Breier A. Pickar D, et al. Among authors: konicki pe. Mod Probl Pharmacopsychiatry. 1990;24:124-51. doi: 10.1159/000418015. Mod Probl Pharmacopsychiatry. 1990. PMID: 1970851 Review.

5

The acute effects of central- and peripheral-acting dopamine antagonists on plasma HVA in schizophrenic patients.

Konicki PE, Owen RR, Litman RE, Pickar D. Konicki PE, et al. Life Sci. 1991;48(14):1411-6. doi: 10.1016/0024-3205(91)90438-h. Life Sci. 1991. PMID: 2008157

6

Outcome of clozapine therapy for elderly patients with refractory primary psychosis.

Sajatovic M, Jaskiw G, Konicki PE, Jurjus G, Kwon K, Ramirez LF. Sajatovic M, et al. Among authors: konicki pe. Int J Geriatr Psychiatry. 1997 May;12(5):553-8. Int J Geriatr Psychiatry. 1997. PMID: 9193964

7

Clozapine reduces water-drinking behavior in schizophrenic patients with polydipsia.

Fuller MA, Jurjus G, Kwon K, Konicki PE, Jaskiw GE. Fuller MA, et al. Among authors: konicki pe. J Clin Psychopharmacol. 1996 Aug;16(4):329-32. doi: 10.1097/00004714-199608000-00010. J Clin Psychopharmacol. 1996. PMID: 8835710

8

Phenylpropanolamine appears not to promote weight loss in patients with schizophrenia who have gained weight during clozapine treatment.

Borovicka MC, Fuller MA, Konicki PE, White JC, Steele VM, Jaskiw GE. Borovicka MC, et al. Among authors: konicki pe. J Clin Psychiatry. 2002 Apr;63(4):345-8. doi: 10.4088/jcp.v63n0412. J Clin Psychiatry. 2002. PMID: 12000209 Clinical Trial.

9

Effect of clozapine on motor function in schizophrenic patients.

Vrtunski PB, Konicki PE, Kwon KY, Jurjus G, Jaskiw GE. Vrtunski PB, et al. Among authors: konicki pe. Schizophr Res. 1996 May;20(1-2):187-98. doi: 10.1016/0920-9964(95)00085-2. Schizophr Res. 1996. PMID: 8794509

10

Clozapine-induced urinary incontinence: incidence and treatment with ephedrine.

Fuller MA, Borovicka MC, Jaskiw GE, Simon MR, Kwon K, Konicki PE. Fuller MA, et al. Among authors: konicki pe. J Clin Psychiatry. 1996 Nov;57(11):514-8. doi: 10.4088/jcp.v57n1102. J Clin Psychiatry. 1996. PMID: 8968299 Clinical Trial.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

24 results

Search Page

Filters